文献速递免疫规划慢病防控与筛查

HPV疫苗接种对美国14-26岁女性疫苗型HPV感染率种族差异的影响

Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
PubMed 文献 · Vaccine · 2018-10-28

该研究回顾性分析2003-2014年6轮NHANES数据,纳入4080名14-26岁女性,比较疫苗接种前与上市后疫苗型HPV(6/11/16/18)感染率变化。结果显示疫苗型HPV感染率仅在2011-2014年显著下降(14.2% vs 5.2%,p<0.001),且白种女性降幅最大(15.2% vs 4.1%,p<0.001),黑人和墨西哥裔美国女性降幅较小或不显著,种族与时间交互作用显著(p<0.001),接种率不均衡是差异来源之一。

要点

  • 疫苗型HPV感染率总体从14.2%降至5.2%(2011-2014年 vs 2003-2006年,p<0.001)。
  • 白种女性降幅最大(15.2%→4.1%,p<0.001),黑人女性降幅较小(16.9%→9.8%,p<0.05)。
  • 墨西哥裔美国女性感染率下降无统计学意义(8.2%→4.0%,p>0.05)。

核心结论

  • 黑人和墨西哥裔美国女性HPV疫苗接种率低,导致疫苗型HPV感染率种族差异持续存在。
  • 提高所有青少年尤其是11-12岁儿童的接种率对减少差异至关重要。

研究设计与样本

  • 回顾性分析6轮NHANES数据(2003-2014年),纳入4080名14-26岁有HPV接种信息的女性。
  • 使用阴道样本HPV状态,比较疫苗接种前(2003-2006年)与上市后(2011-2014年)的疫苗型HPV感染率。

主要发现

  • 疫苗型HPV感染率仅在2011-2014年显著低于接种前(14.2% vs 5.2%,p<0.001)。
  • 白种女性感染率从15.2%降至4.1%(p<0.001),黑人女性从16.9%降至9.8%(p<0.05),墨西哥裔美国女性从8.2%降至4.0%(p>0.05)。
  • 种族与时间交互作用显著(p<0.001),黑人与白种女性接种率不均衡贡献了观察到的差异。

临床怎么用

  • 应重点提高黑人和墨西哥裔美国青少年HPV疫苗接种率,尤其11-12岁年龄段。
  • 监测不同种族/族裔HPV感染率变化,评估接种公平性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low human papillomavirus (HPV) vaccination rates early after introduction, particularly among low income and minority adolescents, may have resulted in disparities in vaccine-type HPV prevalence (types 6, 11, 16, 18). The purpose of this study was to examine racial/ethnic variations in HPV prevalence, and evaluate how HPV vaccination has affected vaccine-type HPV prevalence across time. METHODS: This study was a retrospective analysis of 6 cycles of the National Health and Nutrition Examination Survey (NHANES) data (2003-2014). Results on HPV status from vaginal samples of 14-26 year old females who responded about HPV vaccination were used to determine HPV prevalence. Prevaccine HPV prevalence was compared to post-licensure prevalence. Racial/ethnic comparisons were made across time, and models were developed to examine the role of HPV vaccination in observed variations for vaccine-type HPV prevalence. RESULTS: Among 4080 females, 29.7% were black, 25.6% were Mexican American, 8.9% were Hispanic, and 35.8% were white. Compared to prevaccine years (2003-2006), vaccine-type HPV did not decrease until late post-licensure years (2011-2014; 14.2% vs. 5.2%, p < 0.001). Most of the decrease occurred among white females between prevaccine and late post-licensure periods (15.2% vs. 4.1%, p < 0.001). Although a decrease in prevalence was observed among black females during the same periods (16.9% vs. 9.8%, p < 0.05), it was not as large as among white females. Prevalence decreased among Mexican Americans (8.2 vs. 4.0, p > 0.05) during the same periods, but the difference was not significant. Interactions between race and time were significant (p < 0.001), with uneven vaccination between black and white females contributing to the disparities observed. CONCLUSIONS: HPV vaccination was low in among black and Mexican American females, which contributed to disparities in HPV prevalence. Increasing vaccination among all adolescents, particularly 11-12 year olds, is important because most children this age will not have been exposed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hirth J, McGrath CJ, Kuo YF, et al. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S. Vaccine. 2018. PMID: 30377066. doi:10.1016/j.vaccine.2018.10.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。